ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,961Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1479

$908K Total Retail Price of All Prescriptions

Rank: 7 out of 1479

962 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 962 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

1% of this provider’s 962 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 24,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$30 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
RANITIDINE HCL 1,477 1,161 1 4
METFORMIN HCL 1,378 1,133 2 2
PRAVASTATIN SODIUM 1,118 856 3 27
ENALAPRIL MALEATE 988 808 4 3
TRAMADOL HCL-ACETAMINOPHEN 884 676 5 18
GLIPIZIDE 788 624 10 6 13
AMLODIPINE BESYLATE 716 630 7 6
OMEPRAZOLE 712 596 8 7
LOSARTAN POTASSIUM 687 572 9 8
LEVOTHYROXINE SODIUM 653 549 10 9
ATENOLOL 646 553 11 11
FUROSEMIDE 623 544 12 15
GABAPENTIN 611 443 13 5
SYNTHROID 503 430 14 12
PENTOXIFYLLINE 494 411 10 15 40
LOSARTAN-HYDROCHLOROTHIAZIDE 449 368 16 14
METOPROLOL TARTRATE 405 287 17 17
ASPIRIN EC 402 363 18 24
HYDROCHLOROTHIAZIDE 367 322 19 10
VERAPAMIL ER 350 222 20 34
ISOSORBIDE MONONITRATE ER 346 293 21 31
SIMVASTATIN 330 306 22 1
ZOLPIDEM TARTRATE 326 257 23 23
ALENDRONATE SODIUM 316 275 24 19
SULINDAC 313 178 25 62
NABUMETONE 286 243 26 22
HUMULIN 70-30 285 254 27 43
DONEPEZIL HCL 284 274 28 45
LISINOPRIL 265 243 29 16
TRAMADOL HCL 228 184 30 20
CLOPIDOGREL 219 205 31 46
SERTRALINE HCL 218 196 32 38
NAMENDA 216 206 33 69
CARVEDILOL 214 211 34 32
INSULIN SYRINGE 200 182 35 30
DICLOFENAC POTASSIUM 195 177 36 29
SINGULAIR 189 162 37 74
CIPROFLOXACIN HCL 188 162 38 26
CILOSTAZOL 181 151 39 65
MECLIZINE HCL 180 145 40 50
ALBUTEROL SULFATE 177 156 41 119
PLAVIX 175 161 42 52
DOXAZOSIN MESYLATE 175 170 42 33
HUMULIN N 167 164 44 42
FAMOTIDINE 166 165 45 47
DIGOXIN 161 147 46 61
PANTOPRAZOLE SODIUM 158 111 47 48
PROAIR HFA 158 83 47 80
PHENYTOIN SODIUM EXTENDED 155 138 49 132
NAPROXEN 151 123 50 57
THEOPHYLLINE ANHYDROUS 150 131 51 125
CLONIDINE HCL 147 110 52 71
CAPTOPRIL 144 115 53 28
LATANOPROST 133 114 54 116
SPIRONOLACTONE 133 133 54 94
TAMSULOSIN HCL 131 130 56 36
SILVER SULFADIAZINE 123 113 57 130
AZITHROMYCIN 119 102 58 25
GEMFIBROZIL 116 63 59 49
WARFARIN SODIUM 115 115 60 83
CLOTRIMAZOLE-BETAMETHASONE 115 95 60 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 100 62 66
SUCRALFATE 112 94 63 135
LANTUS 111 98 64 35
LEVOXYL 111 106 64 44
LANSOPRAZOLE 107 76 66 92
DIOVAN 107 95 66 85
BETAMETHASONE DIPROPIONATE 107 85 66 91
ISOSORBIDE DINITRATE 102 67 69 82
BRIMONIDINE TARTRATE 98 87 70 300
CALTRATE 600 + D 94 90 71 157
DILTIAZEM 24HR CD 93 72 72 156
IRBESARTAN 92 72 73 78
NAPROXEN SODIUM 88 47 74 87
EVISTA 88 57 74 79
MONTELUKAST SODIUM 84 69 76 217
BUMETANIDE 78 71 77 161
ATORVASTATIN CALCIUM 78 53 77 41
CYCLOBENZAPRINE HCL 77 17 R 79 175
PERMETHRIN 77 73 79 200
PREDNISONE 76 41 81 67
DIVALPROEX SODIUM 75 45 82 142
DIPYRIDAMOLE 71 69 R 83 56
TRAZODONE HCL 71 57 83 122
RISPERIDONE 70 65 85 88
ORPHENADRINE CITRATE 68 30 R 86 118
GLIMEPIRIDE 67 67 87 21
DIOVAN HCT 67 60 87 86
CARBIDOPA-LEVODOPA 66 65 89 184
LEVOFLOXACIN 66 59 89 115
CLOBETASOL PROPIONATE 65 52 91 133
AMLODIPINE BESYLATE-BENAZEPRIL 64 60 92 54
VERAPAMIL HCL 64 55 92 173
AMITRIPTYLINE HCL 63 29 R 94 106
JANUVIA 62 44 95 107
GLYBURIDE-METFORMIN HCL 62 57 R 95 53
LACTULOSE 60 43 97 172
LYRICA 59 33 98 99
ADVAIR DISKUS 58 35 99 104
QUETIAPINE FUMARATE 58 48 99 108
ENDOCET 57 27 S2 101 148
DILTIAZEM HCL 56 56 102 111
AMOX TR-POTASSIUM CLAVULANATE 53 45 103 81
FLUTICASONE PROPIONATE 52 39 104 64
MEGESTROL ACETATE 50 50 R 105 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.